* HELLO *
AND WELCOME
A DEDICATED COMPANY, WITH SOLID CREDENTIALS & AND AN EXTENSIVE FOOTPRINT IN PHARMA
READ MOREOUR WORK
HEALTH
IS EVERYTHING
WE ARE PART OF THE SOLUTION WHEN IT COMES TO UNIVERSAL ACCESS TO GOOD QUALITY MEDS
NEWSSTORIES
PHARMA
MARKETS
WE UNDERSTAND HOW TO GET YOUR PRODUCTS TO MARKET EFFICIENTLY AND WITH EASE
LEARN MOREGALLERY

Our Services

Clinical Research Development

At Pharma Strategies, we ensure that our clients optimally balance time, risk and cost in order to maximize the potential of a product…. Read More

Innovation Management

It is our observation that Pharma’s innovation focus remains on products and business models, and as such, Pharma Strategies …. Read More

Product Development Strategy

At Pharma Strategies, we combine clinical and commercial insights to transform your product development. Read More

New Market Access

Everybody’s talking about market access. But far fewer appear able to define it. In the competitive world of pharmaceutical … Read More

Business Development

Developing your business – through partnering, acquisition, licensing – and expanding your portfolio: a big ask in tough … Read More

Marketing & Education

Pharma Strategies is heavily involved in the provision of Marketing Excellence and Continuous Medical Education Read More

Why us?

We have the tools

We have all the tools necessary to execute complex tasks so that you dont have to!

Certified Experience

We are certfied industry leaders with an established footprint spanning many years.

Industry Experience

Our collective extensive experience and knowledge is over 30 years strong.

Smart Partnerships

We believe in smart partnerships. Therefore, our solutions are distinguished, tried, and tested.

Stakeholder Relationships

Our work spans across both the public and private sectors alike. We understand the dynamics of each.

Great Support

Our team is brilliant! We are here for the long haul & value each relationship, old and new.

Some of our Products

Latest News

Novartis and the Bill & Melinda Gates Foundation collaborate to discover and develop an accessible in vivo gene therapy for sickle cell disease

Project brings together Novartis drug discovery and gene therapy expertise and funding support from the Gates Foundation Agreement aims to address disparity in access to treatments and to prioritize populations and regions that bear the greatest burden…

Novartis Entresto® granted expanded indication in chronic heart failure by FDA

Entresto is the first and only therapy approved in the US to treat patients diagnosed with guideline-defined heart failure to include both those with heart failure with reduced ejection fraction (HFrEF) and many with heart failure with preserved ejecti…

© Copyright - Pharma Strategies | Zimbabwe